Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Combining RU58841 and minoxidil significantly increases hair growth.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Researchers made stem cells from human hair follicle cells with higher efficiency than from skin cells.

The comprehensive treatment with biomimetic peptide lotion was effective for hair loss.

Patients with non-scarring alopecia often experience emotional disorders like depression and stress.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Early treatment with corticosteroids improved her eye condition significantly.

Exosomes show promise for diagnosing and treating skin conditions and hair loss.

Environmental factors and grain products affect hair loss, with low cobalt in hair possibly predicting the condition.

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Women with menstrual dysfunction often have deficiencies in magnesium, iron, and vitamin D.

Electrical and chemical skin stimulation can improve hair growth.

Combining iron supplements with physiotherapy could better treat women's hair loss linked to iron deficiency.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Iron supplements and physiotherapy together can better treat hair loss in women with iron deficiency.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Phytochemicals in hair masks can help with damaged hair, seborrhea, and hair loss.

Alopecia X causes hair loss in young plush-coated dogs and can be treated with various therapies, but hair may regrow and then fall out again.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.